Hydrophilic interaction chromatography-tandem mass spectrometry of donepezil in human plasma: Application to a pharmacokinetic study of donepezil in volunteers

Archives of Pharmacal Research

Volumn 31, Issue 9, 2008, Pages 1205-1211

  Park, Een Jeong ^a   Lee, Hye Won ^a   Ji, Hye Young ^a   Kim, Hoe Yoon ^a,b   Lee, Mann Hyung ^a,c   Park, Eun Seok ^a,b   Lee, Kang Choon ^a,b   Lee, Hye Suk ^a  

^a Wonkwang University   (South Korea)

^b Sungkyunkwan University   (South Korea)

^c Catholic University of Daegu   (South Korea)

Author keywords

Donepezil; HILIC MS MS; Human plasma

Indexed keywords

DONEPEZIL; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; INDAN DERIVATIVE; NOOTROPIC AGENT; PIPERIDINE DERIVATIVE;

ADULT; ARTICLE; BLOOD; CALIBRATION; DRUG STABILITY; ELECTROSPRAY MASS SPECTROMETRY; FREEZING; HUMAN; LIQUID CHROMATOGRAPHY; MALE; QUALITY CONTROL; REPRODUCIBILITY; STANDARD; TANDEM MASS SPECTROMETRY;

ADULT; CALIBRATION; CHROMATOGRAPHY, LIQUID; DRUG STABILITY; FREEZING; HUMANS; INDANS; INDICATORS AND REAGENTS; MALE; NOOTROPIC AGENTS; PIPERIDINES; QUALITY CONTROL; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY;

EID: 52649107575     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-001-1290-6     Document Type: Article

References (21)

1. C. Apostolou Y. Dotsikas C. Kousoulos Y. L. Loukas 2007 Quantitative determination of donepezil in human plasma by liquid chromatography/tandem mass spectrometry employing an automated liquid-liquid extraction based on 96-well format plates. Application to a bioequivalence study J. Chromatogr. B 848 239 244
2. B. Dejaegher D. Mangelings Y. V. Heyden 2008 Method development for HILIC assays J. Sep. Sci. 31 1438 1448
3. J. Haginaka C. Seyama 1992 Determination of enantiomers of 1-Benzyl-4[(5,6-dimethoxy-indanon)-2-yl]methylpiperidine hydrochloride (E2020), a centrally acting acetylcholine esterase inhibitor, in plasma by liquid chromatography with fluorometric detection J. Chromatogr. B 577 95 102
4. Z. Hao B. Xiao N. Weng 2008 Impact of column temperature and mobile phase components on selectivity of hydrophilic interaction chromatography (HILIC) J. Sep. Sci. 31 1449 1464
5. P. Hemstrom K. Irgum 2006 Hydrophilic interaction chromatography J. Sep. Sci. 29 1784 1821
6. Y. Hsieh 2008 Potential of HILIC-MS in quantitative bioanalysis of drugs and drug metabolites J. Sep. Sci. 31 1481 1491
7. D. W. Jeong Y. H. Kim H. Y. Ji Y. S. Yoon K. C. Lee H. S. Lee 2007 Analysis of carvedilol in human plasma using hydrophilic interaction liquid chromatography with tandem mass spectrometry J. Pharm. Biomed. Anal. 44 547 552
8. H. Y. Ji D. W. Jeong Y. H. Kim H. H. Kim Y. S. Yoon K. C. Lee H. S. Lee 2006 Determination of gabapentin in human plasma using hydrophilic interaction liquid chromatography with tandem mass spectrometry Rapid Comm. Mass Spectro. 20 2127 2132
9. H. Y. Ji E. J. Park K. C. Lee H. S. Lee 2008 Quantification of doxazosin in human plasma using hydrophilic interaction liquid chromatography with tandem mass spectrometry J. Sep. Sci. 31 1628 1633
10. H. Lee J. Seo I. Kang H. Lee J. Ryu K. T. Lee 2007 Bioequivalence of donepezil™ tablet to Aricept™ tablet (donepezil hydrochloride 10 mg) J. Kor. Pharm. Sci. 37 57 62
11. K. Matsui Y. Oda H. Ohe S. Tanaka N. Asakawa 1995 Direct determination of E2020 enantiomers in plasma by liquid chromatography-mass spectrometry and columnswitching techniques J. Chromatogr. A 694 209 218
12. K. Matsui Y. Oda H. Nakata T. Yoshimura 1999 Simultaneous determination of donepezil (Aricept®) enantiomers in human plasma by liquid chromatography-electrospray tandem mass spectrometry J. Chromatogr. B 729 147 155
13. B. K. Matuszewski M. L. Constanzer C. M. Chavez-Eng 2003 Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS Anal. Chem. 75 3019 3030
14. D. V. McCalley 2007 Is hydrophilic interaction chromatography with silica columns a viable alternative to reversed-phase liquid chromatography for the analysis of ionisable compounds? J. Chromatogr. A 1171 46 55
15. W. Naidong 2003 Bioanalytical liquid chromatography-tandem mass spectrometry methods on underivatized silica columns with aqueous/organic mobile phases J. Chromatogr. B 796 209 224
16. 30 column J. Pharm. Biomed. Anal. 41 201 206
17. I. B. Paek Y. Moon H. Y. Ji H. H. Kim H. W. Lee Y. B. Lee H. S. Lee 2004 Hydrophilic interaction liquid chromatography-tandem mass spectrometry for the determination of levosulpiride in human plasma J. Chromatogr. B 809 345 350
18. M. Thevis F. Wilkens H. Geyer W. Schanzer 2006 Determination of therapeutics with growth-hormone secretagogue activity in human urine for doping control purposes Rapid Comm. Mass Spectro. 20 3393 3402
19. P. J. Tiseo K. Foley L. T. Friedhoff 1998 An evaluation of the pharmacokinetics of donepezil HC1 in patients with moderately to severely impaired renal function Br. J. Clin. Pharmacol. 46 suppl.1 56 60
20. Z. Xie Q. Liao X. Xu M. Yao J. Wan D. Liu 2006 Rapid and sensitive determination of donepezil in human plasma by liquid chromatography/tandem mass spectrometry: application to a pharmacokinetic study Rapid Comm. Mass Spectro. 20 3193 3198
21. N. Yasui-Furukori R. Furuya T. Takahata T. Tateishi 2002 Determination of donepezil, an acetylcholinesterase inhibitor, in human plasma by high-performance liquid chromatography with ultraviolet absorbance detection J. Chromatogr. B 768 261 265